BioLife Solutions Inc.
BLFSBioLife Solutions Inc. (BLFS) is a provider of biopreservation tools and systems for the long-term storage of cells, tissues, and organs. The company develops and markets advanced cryopreservation media, controlled-rate thawing systems, and other bioprocessing products primarily serving the biopharmaceutical, cell and gene therapy, and regenerative medicine industries. BioLife Solutions aims to improve the safety and efficacy of cell-based therapies through its innovative preservation technology.
Company News
BioLife Solutions reported Q4 2025 revenue from continuing operations of $24.8 million, up 20% year-over-year, and full-year 2025 revenue of $96.2 million, exceeding guidance and representing 29% growth. The company, now positioned as a pure-play cell processing company following the divestiture of its evo product line, expects continued revenue ...
BioLife Solutions' CFO Troy Wichterman sold 30,000 shares for $771,600, representing 16.4% of his direct holdings. The company reported Q3 revenue growth of 31.2%, but the stock has underperformed market indexes over the past year.
The global cell therapy packaging market is projected to grow from $419.57 million in 2025 to $1.27 billion by 2034, driven by increasing demand for cell and gene therapies, technological advancements, and specialized packaging solutions.
The cell and gene therapy infrastructure market is projected to experience significant revenue growth from 2025 to 2034, driven by increasing demand for advanced therapeutic development, manufacturing capacity expansion, and technological advancements.
BioLife Solutions announced its management will participate in multiple investor conferences in November and December 2025, including events in Napa Valley, Nashville, London, and virtual conferences focused on small-cap and healthcare sectors.
